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ABSTRACT 
Keratoconus, a common inherited ocular disorder resulting in progressive corneal thinning, is 
the leading indication for corneal transplantation in the developed world. Genome-wide 
association studies have identified common SNPs 100kb upstream of ZNF469 strongly 
associated with corneal thickness. Homozygous mutations in ZNF469 and PRDM5 genes 
result in brittle cornea syndrome type 1 and type 2 respectively. Brittle cornea syndrome is an 
autosomal recessive generalized connective tissue disorder associated with extreme corneal 
thinning and a high risk of corneal rupture. Some individuals with heterozygous PRDM5 
mutations in these brittle corneal syndrome genes demonstrate a carrier ocular phenotype, 
which includes a mildly reduced corneal thickness, keratoconus and blue sclera. We 
hypothesized that heterozygous variants in PRDM5 and ZNF469 predispose to the 
development of isolated keratoconus. We found a significant enrichment of potentially 
pathologic heterozygous alleles in ZNF469 associated with the development of keratoconus 
(P=0.00102) resulting in a relative risk of 12.0. This enrichment of rare potentially 
pathogenic alleles in ZNF469 in 12.5% of keratoconus patients represents a significant 
mutational load, and highlights ZNF469 as the most significant genetic factor responsible for 
keratoconus identified to date. 
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INTRODUCTION 
Keratoconus (MIM 148300), a common bilateral, progressive corneal thinning disorder (1), is 
the leading indication for corneal transplantation in the developed world, accounting for 25% 
of the 2500 corneal transplants performed annually in the UK and a similar proportion of the 
32000 grafts performed annually in the USA (2). Keratoconus usually arises in the teenage 
years and presents a significant health burden in work-age adults. The minimum incidence is 
1 in 2000 but it is much more common in some ethnic groups (1, 3) . There is strong evidence 
for a heritable component in the development of keratoconus (4, 5). Most studies describe 
autosomal dominant inheritance, with incomplete penetrance or variable expressivity (4). 
However, in a genetic modelling study in a multi-ethnicity population a major recessive 
genetic defect was the most parsimonious (6), although no recessive loci for keratoconus 
have been described to date. 
The progressive corneal thinning associated with keratoconus (mean central corneal thickness 
450-500 µm) (7) results in myopia and irregular corneal astigmatism. In healthy humans 
central corneal thickness (CCT) is a normally distributed quantitative trait with a mean of 536 
µm ± 31 µm (8) which has an estimated heritability up to 95% (9). Genome-wide association 
studies (GWAS) in the healthy European and Asian populations have identified CCT - 
associated loci, with common SNPs upstream of zinc finger 469 (ZNF469 [MIM 612078]) the 
most strongly associated with CCT (10-14).  Mutations in three genes (ZNF469, COL5A1 
and COL8A2) close or within these identified loci are responsible for rare Mendelian 
conditions that affect the corneal structure: brittle corneal syndrome, Ehlers-Danlos syndrome 
and posterior polymorphous corneal dystrophy respectively (10-12). 
Brittle cornea syndrome (BCS) is an autosomal recessive generalized connective tissue 
disorder associated with extreme corneal thinning (220-450 µm) and a high risk of corneal 
Page 4 of 32Human Molecular Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
5 
 
rupture (15, 16). Homozygous mutations in ZNF469 and PR domain-containing protein 5 
(PRDM5 [MIM 614161]) genes result in brittle cornea syndrome type 1 (BCS1 [MIM 
229200]) (17) and brittle cornea syndrome type 2 (BCS2 [MIM 614170]) (15) respectively. 
Some individuals with heterozygous PRDM5 mutations demonstrate a carrier ocular 
phenotype which includes a mildly reduced CCT (480-505µm), keratoconus and blue sclera 
(15). In one family with BCS2 there was a relationship between the severity and age of onset 
of keratoconus and PRDM5 mutational status. Family members with a homozygous PRDM5 
mutation (deletion of exons 9–14) developed early and severe keratoconus whereas one 
heterozygous family member developed keratoconus which was clinically milder with a later 
onset (15). The relationship between the degree of CCT reduction and the presence of 
homozygous or heterozygous mutations in PRDM5 suggested a dosage effect (15). Although 
none of the CCT-associated loci have been mapped to PRDM5, a common SNP (rs10518367) 
which is 70 kb upstream of  PRDM5 has been associated with CCT in the European 
population at the significance level of P = 8.9 × 10
−5
. 
Given that rare ZNF469 and PRDM5 homozygous mutations result in the extreme corneal 
thinning disorder (BCS), and that there was evidence of a carrier ocular phenotype 
(keratoconus and corneal thinning) in some individuals with PRDM5 heterozygous 
mutations, and that common SNPs 100kb upstream of ZNF469 are strongly associated with 
CCT, we undertook Sanger sequencing of both genes in patients with isolated keratoconus; a 
common ocular disease chracterised by progressive corneal thinning and ectasia.  
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RESULTS 
Heterozygous PRDM5 mutations in carrier individuals from BCS2 families can result in 
keratoconus (15) and so the entire coding region and intron-exon junctions of PRDM5 (exons 
1-16) were sequenced in an initial 96 unrelated European patients with keratoconus. This 
analysis failed to identify any pathogenic variants, although eight known SNPs were detected 
(rs146268537, rs74320998, rs343192, rs17051264, rs34666716, rs12499000, rs75893420 and 
rs55774575). We therefore proceeded to Sanger-sequence ZNF469 in the original cohort 
increased with additional keratoconus cases (total number of cases = 112) of  unrelated 
European patients with keratoconus from three study centres (Belfast, Leeds and Lausanne). 
Sequence variants of unknown significance (VUS) detected by Sanger sequencing were 
classified as potentially pathogenic alleles by filtering using (i) ethnically matched population 
specific control data from 784 individuals (outlined in the Methods); (ii) the data from dbSNP 
(Build 137), the May 2012 release of the 1000 Genomes (1KG) Project and the Exome 
Variant Server (EVS), NHLBI Exome Sequencing Project (ESP), with no allele having a 
minor allele frequency (MAF) of > 0.1%; and (iii) classified as damaging using the Sorting 
Intolerant from Tolerant (SIFT) program as outlined in the Methods and Figure 2.  
From this stringently filtered sequencing data 12 potentially pathogenic non-synonymous 
heterozygous alleles were detected in the keratoconus cohort (Table 1) and 2 in-frame 
deletions: c.2904_2909delGTCGGG; p.Ser969_Gly970del and 
c.9011_9025delTTCCCGGGAACACCC; p.Leu3004_Thr3008del.  In the keratoconus cohort 
following filtering there remained 15 non-synonymous classified as tolerated by SIFT which 
were absent from control data and had a MAF <0.1% (Table 2). On the basis of poor 
conservation 6 of these variants were classified as polymorphisms leaving 9 variants of 
unknown significance.  We detected 34 non-synonymous and 33 synonymous variants which 
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were observed in both cases and controls, had a MAF > 0.1% or were common variants, and 
were deemed non-pathogenic (Supplemental Table 1, available online). Overall, this study 
identified 34 novel variants (29 non-synonymous and 5 synonymous) which have been 
submitted to the NCBI dbSNP (Supplemental Table 2, available online). The severity of 
keratoconus was graded using the Amsler-Krumeich classification (18, 19) and 10 individuals 
had grade stage III or above indicating severe disease (illustrated in Figure 1). Stages III and 
IV usually require surgical approaches for visual rehabilitation and 3 individuals required 
corneal transplantation. 
As there was the possibility that the alleles identified in the keratoconus subjects represented 
chance events, we Sanger-sequenced the complete coding sequence of ZNF469 (13,203 bp) 
in 96 unaffected and unrelated European control samples (192 chromosomes) using the same 
experimental stringency as the case sequencing, and detected 1 non-synonymous 
heterozygous allele (c.1701G>T; p.Gln567His) deemed potentially pathogenic given our 
filtering criteria (Table 1). There was a statistically significant enrichment of potentially 
pathogenic ZNF469 alleles in the keratoconus subjects (14 variants) compared with the 96 
European controls (1 variant); P=0.00102 (Odds Ratio 13.6, Relative Risk 12.0).  The allele 
frequency differences make it impossible for the rare ZNF469 alleles to be in linkage 
disequilibrium with the common variant signal which is within a 53 kb linkage 
disequilibrium block 117kb away from the 5' end of ZNF46, and this has been replicated in 
diverse ancestries groups. The common variant, although strongly associated with corneal 
thickness, is not strongly associated with keratoconus (OR 1.25(95% CI 1.11-1.40)) (13.). 
Further functional studies and assays are required to confirm the pathogenicity of all alleles 
absent from ethnically matched controls and the population control data (dbSNP, EVS, 1KG).  
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DISCUSSION 
Mutations in four genes, VSX1 (MIM 605020)(20, 21), SOD1 (MIM 147450)(21, 22),  
MIR184 (MIM 613146)(23) and  ZEB1 (MIM 189909) (24), have been implicated in the 
pathogenesis of keratoconus in a minority of cases (< 4%) (21, 25). Two GWAS have been 
conducted in keratoconus cohorts which identified a SNP rs4954218, located near the 
RAB3GAP1 gene (MIM 602536)(26), and polymorphisms in HGF (MIM 142409)(27), 
associated with keratoconus susceptibility, but neither study reported genome-wide 
significant association. The identification of alleles that are predicted to be potentially 
pathogenic in 12.5% of keratoconus patients (11/112) makes ZNF469 the most significant 
genetic factor responsible for keratoconus identified to date. The small sizes of unrelated 
keratoconus cases cohorts favour a candidate genes approach so that while the p-value 
obtained for evidence of a burden of ZNF469 rare damaging variants in the keratoconus cases 
is statistically significant, it would not have been in a genome-wide context.  
 
Brittle cornea syndrome is a rare recessive connective tissue disorder associated with 
consanguinity, with most BCS patients originating from countries in the Middle East and 
North Africa(16). ZNF469, the gene for BCS1, was originally mapped to chromosome 16q24 
in a single large Palestinian family and a homozygous frameshift mutation, (c.9527delG) 
predicted to result in a premature termination codon (p.Gln3178ArgfsX23), was subsequently 
reported (17). Five further homozygous ZNF469 mutations have been reported in the 
literature: a founder mutation in five Tunisian patients (c.5934delA) predicted to result in a 
premature termination codon (p.Gly1983AlafsX16), p.Gln1392X (Syrian origin) (28), 
p.Phe717SerfsX14(15), p.Gln1757X (15) and one homozygous missense mutation 
(p.Cys3339Tyr) in a consanguineous Norwegian family (29). Homozygous mutations in 
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PRDM5 result in BCS2 and in some families PRDM5 heterozygous gene carriers display an 
ocular carrier state which includes a mildly reduced central corneal thickness (CCT; 480-
505µm), keratoconus and blue sclera (15). Families harboring homozygous and heterozygous 
PRDM5 mutations show a gene dosage relationship in terms of the degree of CCT reduction 
and the severity and age of onset of keratoconus(15). There is no data available of CCT 
measurement or corneal topography for heterozygous carriers of ZNF469 mutations in BCS1 
families. Our data for ZNF469 in the keratoconus population mirrors that seen in the ocular 
phenotype of PRDM5 heterozygous carriers. Heterozygous ZNF469 pathological alleles 
result in progressive corneal thinning and ectasia producing the keratoconus phenotype. The 
majority of potentially pathogenic alleles in the keratoconus cohort were missense variants 
likely to have a less deleterious effect on protein function than the ZNF469 truncating 
mutations commonly associated with BCS1. This further supports a gene dosage 
phenomenon wherein homozygous, severely deleterious ZNF469 mutations result in an early 
onset severe and visually devastating ocular phenotype (extreme corneal thinning, ectasia and 
spontaneous rupture) (15), whereas heterozygous, missense ZNF469 mutations result in 
corneal thinning, ectasia and keratoconus. Further functional studies and cell based assays are 
required to interrogate the molecular pathology and mutational mechanisms associated with 
these potentially pathogenic ZNF469 alleles. 
ZNF469 is a 3925 amino acid evolutionarily poorly conserved C2H2 zinc finger (C2H2-
ZNF) protein of unknown function(30). C2H2-ZNF genes constitute the largest class of 
transcription factors in humans making up ~2% of all the human genes and represent the 
second largest gene family in humans (30). The first identified members of the C2H2-ZNF 
family were xenopus TFIIIA and drosophila Kruppel and thus genes of this family are often 
called zinc finger genes of the TFIIIA or Kruppel type(30-32). Most C2H2-ZNF genes code 
for transcription factors which can bind DNA, RNA, DNA-RNA hybrids and proteins (32). 
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The physiological role of ZNF469 is not well established but there is evidence that ZNF469 
regulates extracellular matrix development and maintenance (15). ZNF469 shows 30% 
sequence similarity to the helical parts of COL1A2 (MIM 120160), COL1A1 (MIM 120150) 
and COL4A1 (MIM 120130), all of which are highly expressed in the cornea (17). The 
cornea is composed of 70% collagen, mostly collagen type I, and there is evidence of a 
dysregulation of collagen homeostasis in the keratoconic cornea (33, 34). Corneal thinning 
has been reported in osteogenesis imperfecta(35) which results from mutations in COL1A1 or 
COL1A2. 
We have identified an enrichment of potentially pathogenic alleles in ZNF469 in patients 
with keratoconus. Further work is required to determine the functional impact of these 
variants and the pathways regulated by ZNF469 which are involved in the development of 
keratoconus. Identifying genes responsible for keratoconus may also provide insights into the 
genetic basis for the normal variation in CCT. Decreased CCT has been proposed as a risk 
factor for primary open angle glaucoma (POAG [MIM 137760]), the leading cause of 
irreversible blindness worldwide affecting more than 60 million people(36). Individual 
patients with a thin cornea have a substantially increased risk for developing POAG (37, 38), 
and glaucoma patients with a thin CCT have an increased severity and more rapid 
progression of visual field loss (39). The genetic basis of CCT may provide insights into the 
development of glaucoma. Common SNPs near ZNF469 are the strongest CCT-associated 
loci although the functional role of these SNPs is not known (10-13). The role ZNF469 plays 
in the development of POAG and maintenance of CCT in normal subjects has not been 
determined. Combining resequencing with GWAS has yielded success in identifying rare 
disease associated variants (40, 41). Our study establishes the significant role ZNF469 plays 
in the development of keratoconus.  
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MATERIALS AND METHODS 
All studies adhered to the tenets of the Declaration of Helsinki, and were approved by the 
relevant institutions with all participants giving written informed consent. 
Patients 
Clinically affected keratoconus patients of European ethnicity were recruited as part of 
ongoing studies from Belfast (Belfast Health and Social Care Trust, UK), Leeds (St. James’s 
University Hospital, Leeds, UK) and Lausanne (Jules-Gonin Eye Hospital, Lausanne and 
Institute for Research in Ophthalmology, Sion, Switzerland); and genomic DNA was 
extracted from peripheral blood leukocytes using commercial kits. The diagnosis of 
keratoconus was performed by an experienced ophthalmologist based on well-established 
clinical signs on slit-lamp biomicroscopy and cycloplegic retinoscopy; and a confirmatory 
videokeratographic map obtained using the Topographic Modelling System-1 (Computed 
Anatomy Inc, NY, USA), Orbscan II (Bausch & Lomb, Salt Lake City, UT, USA) or the 
Pentacam (Oculus, Wetzlar, Germany) (20, 27). Slit-lamp biomicroscopy was used to 
identify the key features of keratoconus including stromal corneal thinning, Vogt’s striae, and 
Fleischer rings in affected individuals. The oil droplet sign and scissoring of the red reflex 
were assessed by retinoscopy performed with a fully dilated pupil. Patients were considered 
as having keratoconus if they had at least one clinical sign of the disease in conjunction with 
a confirmatory videokeratography map (20, 27). The severity of keratoconus was graded 
using the Amsler-Krumeich classification (18, 19):  
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Amsler-Krumeich classification 
Stage I 
Eccentric corneal steppening 
Myopia and/or astigmatism <5.00D 
Mean central K readings <48.00D 
Stage II 
Myopia and/or astigmatism 5.00 to 8.00D 
Mean central K readings <53.00D 
Absence of scarring 
Minimal corneal thickness >400 µm 
Stage III 
Myopia and/or astigmatism 8.00 to 10.00D 
Mean central K readings >53.00D 
Absence of scarring 
Minimal corneal thickness 300 to 400 µm 
Stage IV 
Refraction not measurable 
Mean central K readings >55.00D 
Central corneal scarring 
Minimal corneal thickness 200 µm 
 
Ethnically matched population specific control data. 
All affected and control individuals were of European ethnicity and population specific 
control data was obtained from three sources: (1) a total of 96 unrelated individuals (192 
chromosomes) without ocular disease (aged 60 and over) from the Northern Irish population 
(U.K.) underwent Sanger sequencing; (2) exome data from 275 non-glaucomatous 
individuals from the Manchester population (U.K.), which are effectively ethnically identical 
to the Leeds population; and (3) normative control data for 413 normal individuals from 
Lausanne  (Swiss population; European) was obtained from The CoLaus Study 
(http://www.colaus.ch/) (42).  
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DNA Sequencing and Statistical Analysis 
PCR primers for amplification of the 16 exons and flanking intron sequences of PRDM5 were 
designed using Primer3 (v. 0.4.0) software (http://frodo.wi.mit.edu/primer3/)(43) and are 
listed in Supplementary Table S3. PCR and Sanger sequencing of ZNF469 was undertaken 
with primers identical to those previously used by Christensen et al. (29) (personal 
communication) with adapted conditions (Supplementary Table S4). Sequencing results were 
analyzed manually using the sequence analysis software SeqScape 2.1.1 (Applied 
Biosystems, USA). Identified sequence variants were described according to the guidelines 
published by the Human Genome Variation Society. Variants were annotated in accordance 
with Ensembl transcript ENST00000437464 or NCBI NM_001127464.1 (Build 
GRCh37/hg19). The sequence variants were initially classified as variants of unknown 
significance (VUS) and then passed through a series of filtering steps shown in Figure 2.  
If the sequence variants VUS were present in the ethnically matched population specific 
control data they were excluded. The remaining sequence variants VUS were required to 
have a  minor allele frequency (MAF) of  < 0.1% in the data from dbSNP (Build 137), the 
May 2012 release of the 1000 Genomes (1KG) Project and the Exome Variant Server (EVS), 
NHLBI Exome Sequencing Project (ESP). Following this the remaining non-synonymous 
alleles were filtered using SIFT which can identify if an amino acid substitution influences 
protein function resulting in a phenotypic change; classified as damaging or tolerated (44). 
SIFT can distinguish between functionally neutral and deleterious amino acid changes in 
mutagenesis studies and on human polymorphisms (45, 46). There are alternative prediction 
tools that use a combination of methods based on sequence homology, protein structure 
information and physicochemical properties of amino acids for prediction (44). Given that 
ZNF469 is a poorly characterised protein with no verified structural homologs, the SIFT 
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algorithm was applied as SIFT computes a combined score derived from the distribution of 
amino acid residues observed at a given position in the sequence alignment and the estimated 
unobserved frequencies of amino acid distribution calculated from a Dirichlet mixture and 
does not rely on structural or physiochemical information (44).   The conservation of the 
affected amino acid across species was analysed using Homologene 
(http://www.ncbi.nlm.nih.gov/homologene/) and multiple sequence alignment with ClustalX 
(http://www.clustal.org/) visualised with GeneDoc software 
(http://www.nrbsc.org/gfx/genedoc/). 
The collapsing method (47) was used to compare the frequency of remaining potentially 
pathogenic alleles between case and control subjects with the level of significance set to p < 
0.05. “This method involves collapsing genotypes across variants and applying a univariate 
test which is powerful for analysing rare variants (47). Specifically, each individual was 
assigned an indicator variable that takes the value 1 if the subject carries at least one 
potentially pathogenic variant and zero otherwise. Whether the proportions of individuals 
with index variable 1 differ significantly in cases and controls was tested using a Fisher exact 
test on the corresponding contingency table of indicator variable counts.” The estimated odds 
ratio (OR), relative risk (RR), 95% confidence interval (CI) and Fisher exact p-value were 
calculated using JavaStat (http://statpages.org/ctab2x2.html). 
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Web Resources 
1000 Genomes Project: http://browser.1000genomes.org/index.html 
Exome Variant Server, NHLBI Exome Sequencing Project, Seattle, WA: 
http://evs.gs.washington.edu/EVS/ 
NCBI dbSNP: http://www.ncbi.nlm.nih.gov/snp 
Fischer exact test calculations: http://statpages.org/ctab2x2.html 
Sorting Intolerant from Tolerant (SIFT)  http://sift.jcvi.org/ 
Online Mendelian Inheritance in Man (OMIM): http://www.omim.org/ 
Homologene (http://www.ncbi.nlm.nih.gov/homologene/)  
ClustalX (http://www.clustal.org/) 
GeneDoc software (http://www.nrbsc.org/gfx/genedoc/). 
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 LEGENDS TO FIGURES 
Figure 1: Corneal topography of the 28 year old European patient from the UK with a 
c.3119A>C (p.Lys1040Thr) ZNF469 pathogenic allele (Table1) using Pentacam corneal 
topography; OD indicates right eye and OS left eye. The topography shows the anterior 
corneal steepening (upper images) associated with keratoconus with a large cone centrally in 
the right eye and paracentrally in the left eye with mean central K readings of 72.4 D (OD) 
and 57.3 D (OS) respectively.  The lower images demonstrate the associated corneal thinning 
underlying the cones with a minimum corneal thickness of 318 µm (OD) and 438 µm (OS). 
The keratoconus is Stage III in both eyes (Amsler-Krumeich classification) with a best 
corrected Snellen acuity of 6/36 right and 6/24 left. The patient subsequently underwent a 
deep anterior lamellar keratoplasty (corneal transplant) in the right eye.  
 
Figure 2: Hierarchical flow diagram of filtering process performed on sequence variants 
identified in ZNF469 in keratoconus cohort by Sanger sequencing. 
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TABLES 
Table 1: Potentially Pathologic ZNF 469 Alleles Identified in Keratoconus and Control Subjects. 
 
Page 24 of 32Human Molecular Genetics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
For Peer Review
25 
 
Nucleotide 
Change
a
 
Amino Acid 
Change
a
 
Present 
in 1KG 
data 
(MAF 
(%)) 
Present in 
EVS data 
(MAF 
(%)) 
rs number 
SIFT prediction 
(SIFT Score)
b
 
Amsler-Krumeich 
Classification
c 
Corneal 
Transplantation 
Right Eye Left Eye 
KERATOCONUS COHORT 
c.290C>T p.Pro97Leu No No rs273585617 
Damaging 
(0) 
Stage III Stage II No 
c.337G>A p.Glu113Lys No No NA 
Damaging 
(0) 
Stage II Stage II No 
c.2063C>A p.Thr688Asn No No NA 
Damaging 
(0) 
Stage IV Stage III No 
c.2699C>G p.Pro900Arg No No rs273585618 
Damaging 
(0.02) 
Stage III Stage II Yes; Right eye 
c.2699C>T p.Pro900Leu No No rs273585618 
Damaging 
(0) 
Stage II Stage II No 
c.2904_2909del 
GTCGGG 
p.Ser969_Gly970 
del  (In-frame 
deletion) 
No No NA NA Stage IV Stage III Yes; Right eye 
c.3119A>C p.Lys1040Thr No No rs273585619 
Damaging 
(0) 
Stage III Stage III Yes; Right eye 
c.4363G>T p.Ala1455Ser No No rs116532825 
Damaging 
(0.02) 
Stage I Stage III Yes; Left eye 
c.5464C>A p.Pro1822Thr 
Yes   
(NA) 
No rs74032866 
Damaging 
(0.04) 
Stage I Stage I No 
c.6095C>A p.Ser2032Tyr No No rs273585623 
Damaging 
(0.05) 
Stage II Stage III No 
c.8912G>T p.Gly2971Val No No rs273585625 
Damaging 
(0.04) 
Stage III Stage II No 
c.9011_9025del 
TTCCCGGGA
ACACCC 
p.Leu3004_Thr3008 
del (in-frame 
deletion) 
No No NA NA Stage III Stage II No 
c.9047C>T p.Thr3016Met No No rs273585626 
Damaging 
(0.02) 
Stage II Stage I No 
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a
 ZNF469 Ensembl transcript ENST00000437464 or NCBI NM_001127464.1 (Build GRCh37/hg19) 
b 
Positions with normalized probabilities less than 0.05 are predicted to be damaging, those greater than or equal to 0.05 are predicted to be 
tolerated 
c
Stages described in Methods(18, 19) 
NA : not available or applicable 
 
 
 
 
 
c.11615C>T p.Pro3872Leu No No rs273585630 
Damaging 
(0.03) 
Stage II Stage III No 
NORMAL CONTROLS 
c.1701G>T p.Gln567His No No NA Damaging NA NA NA 
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Table 2: ZNF 469 Sequence Variants of Unknown Significance (VUS) Identified in Keratoconus and Control Subjects.  
 
Nucleotide 
Change 
Amino Acid 
Change 
rs number Present 
in 1KG 
data 
(MAF 
(%)) 
Present in 
EVS data 
(MAF 
(%)) 
SIFT prediction 
 
Classification
a
 
KERATOCONUS COHORT 
Non-Synonymous Variants 
c.77G>C p.Ser26Thr rs273585616 No No Tolerated VUS 
c.1627G>A p.Gly543Ser NA No No Tolerated 
Polymorphism 
(Ser common) 
c.2297G>A p.Arg766Gln rs144492145 
Yes 
(0.05) 
No Tolerated Polymorphism 
c.3236G>A p.Arg1079Gln NA No No Tolerated 
Polymorphism 
(Gln in 
marmoset) 
c.4394C>T p.Pro1465Leu rs369382753 No 
Yes  
(0.02) 
Tolerated 
Polymorphism 
(Leu in rat and 
mouse) 
c.4826G>C p.Arg1609Pro rs273585621 No No Tolerated 
Polymorphism 
(Pro in dog) 
c.5060G>A p.Arg1687Lys NA No No Tolerated VUS 
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c.5597A>T p.Gln1866Leu NA No No Tolerated VUS 
c.6007G>A p.Glu2003Lys rs273585622 No No Tolerated 
Polymorphism 
(Lys in gorilla) 
c.6725C>A p.Ser2242Tyr rs273585624 No No Tolerated VUS 
c.7527G>C p.Glu2509Asp rs199519673 No 
Yes 
(0.090) 
Tolerated VUS 
c.7747G>A p.Glu2583Lys NA No No Tolerated VUS 
c.7847G>A p.Arg2616Gln NA No No Tolerated VUS 
c.9835A>G p.Thr3279Ala rs273585627 No No Tolerated VUS 
c.11101G>A p.Gly3701Ser rs273585629 No No Tolerated VUS 
Synonymous Variants 
c.99G>A p.Pro33Pro rs273585631 No No NA VUS 
c.720G>A p.Glu240Glu rs273585632 No No NA VUS 
c.2478G>T p.Pro826Pro rs273585634 No No NA VUS 
c.6453T>C p.Asp2151Asp NA No  No NA VUS 
c.10843C>T p.Leu3615Leu NA No No NA VUS 
NORMAL CONTROL COHORT 
Non-Synonymous Variants 
c.10115C>T p.Pro3372Leu NA No No Tolerated VUS 
c.11252G>A p.Arg3751Lys NA No No  Tolerated 
Polymorphism 
(Lys in dog) 
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Synonymous Variants 
c.30G>A p.Pro10Pro NA No No NA VUS 
c.4281C>A p.Leu1427Leu NA No No NA VUS 
 
 
 
a
If predicted to be tolerated using SIFT  the conservation of the residue was assessed and if poorly conserved the variant was classified as a 
polymorphism 
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ABBREVIATIONS 
1KG  1000 Genomes 
BCS  Brittle cornea syndrome 
CCT  Central corneal thickness 
CI  Confidence interval 
ESP  Exome sequencing project 
EVS  Exome variant server 
GWAS Genome-wide association study 
MAF  Minor allele frequency 
OR  Odds ratio 
POAG  Primary open angle glaucoma 
RR  Relative risk 
VUS  Variant of unknown significance 
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Figure 1: Corneal topography of the 28 year old European patient from the UK with a c.3119A>C 
(p.Lys1040Thr) ZNF469 pathogenic allele using Pentacam Corneal Topography.  
1200x829mm (65 x 65 DPI)  
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Figure 2: Hierarchical flow diagram of filtering process performed on sequence variants identified in ZNF469 
in keratoconus cohort by Sanger sequencing.  
355x266mm (96 x 96 DPI)  
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